SUVENPHAR.BOSUVENPHAR.BOBSE
Loading
Gross Profit Over TimeExpanding
Percentile Rank100
3Y CAGR+3.3%
5Y CAGR+10.5%
Studio
Year-over-Year Change

Revenue minus cost of goods sold

3Y CAGR
+3.3%/yr
Annual compound
5Y CAGR
+10.5%/yr
Recent deceleration
Percentile
P100
Near historical high
vs 5Y Ago
1.6x
Solid growth
Streak
1 yr
Consecutive growthExpanding
PeriodValueYoY Change
2025$8.22B+20.9%
2024$6.80B-9.6%
2023$7.52B+0.8%
2022$7.46B+30.3%
2021$5.73B+14.6%
2020$5.00B-6.5%
2019$5.34B-